However, HER2+ patients with low inflammatory status showed a trend toward higher pCR rates (SAA: 64% vs. 44%; SII: 63% vs. 38%), a pattern not observed in HER2- patients ( Supplementary Table 1 ).
← all excerpts
Correlation analysis of serum amyloid A, neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and systemic immune-inflammation index with neoadjuvant therapy efficacy and prognosis in breast cancer.
1
—
—